NCT00720785 2026-04-01Natural Killer Cells and Bortezomib to Treat CancerNational Institutes of Health Clinical Center (CC)Phase 1 Completed35 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled